Lv2
200 积分 2024-04-12 加入
A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity
29天前
已完结
The Clinical Profile and Pathophysiology of Atrial Fibrillation
30天前
已完结
Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations
1个月前
已完结
The association between hyperuricemia and atrial fibrillation recurrence after catheter ablation
1个月前
已完结
Effects of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta‐analysis of randomized controlled trials
1个月前
已完结
Definition of hyperuricemia and gouty conditions
1个月前
已完结
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
1个月前
已完结
Emerging therapies: Potential roles of SGLT2 inhibitors in the management of pulmonary hypertension
1个月前
已完结
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
1个月前
已完结
Mechanisms of SGLT2 Inhibitors in Heart Failure and Their Clinical Value
1个月前
已完结
皖公网安备34019202002308
